AI company SandboxAQ is bringing its drug discovery models to Anthropic’s Claude chatbot platform, in a move aimed at making scientific research tools easier to use for researchers and pharmaceutical companies.
The company said its models can now be accessed through Claude, allowing scientists to ask questions in simple language instead of relying on specialised coding.
Drug discovery remains one of the most expensive and time-consuming areas in science, often taking years and billions of dollars to identify a viable molecule. Many AI startups have tried to speed up this process, but most tools still require specialised technical expertise. SandboxAQ claims its Claude integration is designed to lower that barrier.
Disclaimer
We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
